$NIVF vs $PGNY: A Micro-Cap Restructuring Story Compared to a Scaled Fertility Benefits Leader NIVF is a micro-cap, highly volatile restructuring story pivoting beyond its legacy fertility business, while PGNY is an established, profitable fertility-benefits platform with roughly $2 billion in market capitalization. Recent market activity has punished NIVF with steep percentage swings and ongoing dilution from capital raises, whereas PGNY has shown steadier, fundamentally supported trading. PGNY generates positive net income, healthy cash flow, and carries no debt; NIVF is a pre-profitability-scale operator relying on acquisitions and financing.